In summary, we report mutations in AKT-1, PIK3CA and TP53 in a subset of apocrine-eccrine carcinomas including eccrine carcinoma, aggressive digital papillary adenocarcinoma, hidradenocarcinoma, and porocarcinoma. This evidence concerns the gene TP53 and eccrine porocarcinoma.